Recombinant Bacteroides thetaiotaomicron heparin lyase 13A

Cat. No.: X23-08-YM665

Recombinant Bacteroides thetaiotaomicron heparin lyase 13A

Synonym: BtHep13A; Heparatinase

  • Enzyme Commission Number: 4.2.2.7
Product Size
1 mg; 2 mg; 3 mg; 6 mg
Price
Datasheet
MSDS
Properties
Description
Recombinant Bacteroides thetaiotaomicron heparin lyase 13A produced by Escherichia coli, catalyzes the cleavage of endo-1,4-β-galactosaminic bonds between acetylgalactosamine and either glucuronic or iduronic acid. It is produced in Escherichia coli.
Expression System
Escherichia coli
Species
Bacteroides thetaiotaomicron
Concentration
1 mg/mL
Form
Liquid
Purity
≥90%, determined by SDS-PAGE.
Activity
Heparin lyases
Buffer
35 mM NaHepes buffer (pH 7.5), 750 mM NaCl, 200 mM imidazole, 3.5 mM CaCl2, and 25% (v/v) glycerol
Applications
Recombinant Bacteroides thetaiotaomicron heparin lyase 13A can be used for the structural analysis of glycosaminoglycans (GAGs) and participates in the eliminative cleavage of heparan.
Storage
Store at -20°C.
Related Products

Thanksgiving 2024

About Us

CD BioGlyco is a world-class biotechnology company with offices in many countries. Our products and services provide a viable option to what is otherwise available.

Contact Us

Copyright © CD BioGlyco. All rights reserved.
0